Hospitals to put doctors' relationships with pharmaceutical companies under the microscope
The University of Colorado School of Medicine, National Jewish and Denver Health are all reviewing and tightening ethics rules as dozens of doctors defy reporting requirements for drug-company payments that can reach well into six figures.
National Jewish, most of whose doctors have dual roles with CU, said it is conducting its own rules review after a preliminary CU report said doctors were testing ethical boundaries and ignoring or disobeying disclosure rules.
"The status quo is no longer acceptable," said Richard Krugman, dean of the CU medical school.
Denver Health spokeswoman Dee Martinez said the hospital system is also reviewing its ethics policies for potential revision, given the recent outcry about pharmaceutical- company spending.
- As Medicare Advantage Cuts Loom, Disagreement Over Program's Stability
- Surgical Checklists Unused in 10% of Hospitals, CMS Data Shows
- Doctors Feel Pressure to Accept Risk-based Reimbursement
- A Fresh Look at End-of-Life Care
- 3 Insider Tips on Cutting Costs without Strangling Growth
- Heart Attack Patient Costs Skyrocket Beyond 30 Days
- 3 in 4 Patients Want E-mail Consultations
- 4 Tectonic Shifts Shaking Up Healthcare
- ACGME Chief Sees 'Huge' Risk of Error in Proposed Assistant Physician Licensure
- CVS Ramps Up Retail Clinics with Provider Affiliations